Good Prescribing Interventions, made an Impact in Reduced Coartem Usage – a Retrospective Study at the Copperbelt University Health Facility

Kaselekela Ponshano
Additional contact information
Kaselekela Ponshano: Copperbelt University, Zambia

Global Journal of Pharmacy & Pharmaceutical Sciences, 2018, vol. 5, issue 5, 114-120

Abstract: In Zambia, the first line drug in the treatment of confirmed positive cases of Malaria is Artemether plus lumefantrine (Coartem). The retail cost of these drug per course ranges from $3.50 to $4.50 in Zambia which is very expensive to the organisation as well as to a common man. However, irrational prescribing of coartem was identified as the major problem at the Copperbelt University health facility. A study to establish the usage of coartem was conducted for a period of six months from July to December, 2017. The first and the last three months was to establish how this valuable drug was being prescribed before and after the prescribing interventions were introduced respectively. A total of 1,143 courses of coartem were prescribed during the study period. Initially 552,168 and 264 courses of coartem were used in the first three months of the study respectively. After the prescribing interventions were implemented, 54, 50 and 55 courses of coartem were used in the last three months.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555672.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555672.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:5:y:2018:i:5:p:114-120

DOI: 10.19080/GJPPS.2018.05.555672

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().